DVA Volume Alert - DVA 74.49 Davita Healthcare Partners Inc $DVA Hit a high of 74.95 Currently 11/07/14 Last price 74.49 -3.54 -4.54% With a day low of 72.70 and a current volume of 6,663,400.
DVA Davita Healthcare Partners Inc Recent Headline News
DaVita Falls 4.54% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Nov 07, 3:43PM CST
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $72.70 to a high of $74.95. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $77.15 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 74.49 (-3.54)
Watch for DaVita to Potentially Rebound After Falling 4.54% Yesterday
Comtex SmarTrend(R) - Fri Nov 07, 3:42PM CST
DaVita (NYSE VA) traded in a range yesterday that spanned from a low of $72.70 to a high of $74.95. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $77.15 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DVA: 74.49 (-3.54)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of DaVita HealthCare Partners Inc.
Business Wire - Fri Nov 07, 2:19PM CST
Levi & Korsinsky, LLP is investigating DaVita HealthCare Partners Inc. ("DaVita" or the "Company"
(NYSE: DVA) in connection with possible breaches of fiduciary duty by the Board of Directors of the Company.
DVA: 74.49 (-3.54)
DaVita Beats on Q3 Earnings, Down Y/Y; Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:50PM CST
DaVita HealthCare Partners Inc. (DVA) reported third-quarter 2014 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate of 91 cents.
DVA: 74.49 (-3.54), GTIV: 19.56 (-0.04), MOH: 48.75 (+0.15), WLP: 124.15 (-3.65)
Davita Healthcare Partners (DVA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Nov 07, 3:50AM CST
The following Davita Healthcare Partners (DVA) conference call took place on November 6, 2014, 05:00 PM ET. This is a transcript of that earnings call:
DVA: 74.49 (-3.54)
DaVita HealthCare Partners Inc. 3rd Quarter 2014 Results
PR Newswire - Thu Nov 06, 3:01PM CST
DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2014. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2014 was $194.5 million and $583.5 million, or $0.90 and $2.69 per share, respectively, excluding a loss contingency reserve. In addition, adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the nine months ended September 30, 2014 excluded debt refinancing charges. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2014 including these items was $184.1 million and $515.1 million, or $0.85 and $2.38 per share, respectively.
DVA: 74.49 (-3.54)
Centura Health and DaVita HealthCare Partners Form New Joint Venture in Colorado and Kansas
PR Newswire - Thu Nov 06, 5:03AM CST
Centura Health and DaVita HealthCare Partners Inc. (NYSE: DVA) today announced a new joint venture that will offer a differentiated health care delivery model to help optimize health care value and lower costs for consumers in Colorado and Kansas. The two partners will combine their expertise to provide enhanced resources that increase coordination of care, equip care providers with sophisticated analytical tools and focus on prevention.
DVA: 74.49 (-3.54)
Will DaVita Healthcare (DVA) Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:40PM CST
DaVita Healthcare Partners, Inc. (DVA) is set to report third-quarter 2014 earnings on Nov 6, 2014.
MDVN: 112.77 (+7.82), AMSG: 51.50 (+0.16), DVA: 74.49 (-3.54), ALNY: 95.84 (+2.93)
Uptrend Call Working As DaVita Stock Rises 25.3% (DVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:38AM CST
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 25.26% as of today's recent price of $77.86.
DVA: 74.49 (-3.54)
DaVita Kidney Care Highlights National Diabetes Month
PR Newswire - Mon Nov 03, 5:23AM CST
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, joins the fight against diabetes during National Diabetes Month this November by sharing suggestions and resources to help individuals manage the disease.
DVA: 74.49 (-3.54)
DaVita Kidney Care Shares Festive Halloween Recipes
PR Newswire - Fri Oct 31, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, shares a collection of Halloween recipes that are tasty alternatives for individuals on a kidney-friendly diet.
DVA: 74.49 (-3.54)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 67.97 (-0.30), ESRX: 77.87 (-0.05), DVA: 74.49 (-3.54), DGX: 61.69 (-1.07), MD: 62.18 (-0.43)
Why DaVita Healthcare Partners Inc. is 1 of the Biggest Warren Buffett Stocks
Selena Maranjian, The Motley Fool - Motley Fool - Wed Oct 29, 7:31AM CDT
Dialysis patient. Source: DaVita Healthcare Partners If you're in the market for some great stock ideas for your portfolio, it makes sense to study what the smartest and most successful investors own. Few, if any, investors are smarter or more...
DVA: 74.49 (-3.54)
DaVita Rx Opens State-of-the-Art Orlando Pharmacy
PR Newswire - Wed Oct 29, 5:23AM CDT
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today the grand opening of its new Orlando, Florida, pharmacy.
DVA: 74.49 (-3.54)
23.3% Return Seen to Date on SmarTrend DaVita Call (DVA)
Comtex SmarTrend(R) - Mon Oct 27, 9:16AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 23.26% as of today's recent price of $76.62.
DVA: 74.49 (-3.54)
DaVita Kidney Care Finalizes DOJ Settlement
PR Newswire - Wed Oct 22, 7:01PM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), today announced it has finalized its comprehensive settlement with the U.S. Department of Justice and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners.
DVA: 74.49 (-3.54)
DaVita HealthCare Partners to Acquire Colorado Springs Health Partners
PR Newswire - Wed Oct 22, 5:38AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider of population health and kidney care services, today announced that HealthCare Partners has entered into an agreement to acquire Colorado Springs Health Partners (CSHP), a multi-specialty medical group with more than 100 physicians at 11 locations throughout the Pikes Peak region.
DVA: 74.49 (-3.54)
Dr. John Wigneswaran Joins Team at DaVita Kidney Care
PR Newswire - Tue Oct 21, 5:42AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named John Wigneswaran, M.D., as its new vice president of clinical affairs for hospital services.
DVA: 74.49 (-3.54)
DaVita Has Returned 17.0% Since SmarTrend Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 17, 5:09PM CDT
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 17.04% as of today's recent price of $72.75.
DVA: 74.49 (-3.54)
DVA Davita Healthcare Partners Inc Recent Headline News
DaVita Falls 4.54% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Nov 07, 3:43PM CST
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $72.70 to a high of $74.95. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $77.15 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 74.49 (-3.54)
Watch for DaVita to Potentially Rebound After Falling 4.54% Yesterday
Comtex SmarTrend(R) - Fri Nov 07, 3:42PM CST
DaVita (NYSE
VA) traded in a range yesterday that spanned from a low of $72.70 to a high of $74.95. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $77.15 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DVA: 74.49 (-3.54)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of DaVita HealthCare Partners Inc.
Business Wire - Fri Nov 07, 2:19PM CST
Levi & Korsinsky, LLP is investigating DaVita HealthCare Partners Inc. ("DaVita" or the "Company"
(NYSE: DVA) in connection with possible breaches of fiduciary duty by the Board of Directors of the Company. DVA: 74.49 (-3.54)
DaVita Beats on Q3 Earnings, Down Y/Y; Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:50PM CST
DaVita HealthCare Partners Inc. (DVA) reported third-quarter 2014 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate of 91 cents.
DVA: 74.49 (-3.54), GTIV: 19.56 (-0.04), MOH: 48.75 (+0.15), WLP: 124.15 (-3.65)
Davita Healthcare Partners (DVA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Nov 07, 3:50AM CST
The following Davita Healthcare Partners (DVA) conference call took place on November 6, 2014, 05:00 PM ET. This is a transcript of that earnings call:
DVA: 74.49 (-3.54)
DaVita HealthCare Partners Inc. 3rd Quarter 2014 Results
PR Newswire - Thu Nov 06, 3:01PM CST
DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2014. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2014 was $194.5 million and $583.5 million, or $0.90 and $2.69 per share, respectively, excluding a loss contingency reserve. In addition, adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the nine months ended September 30, 2014 excluded debt refinancing charges. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2014 including these items was $184.1 million and $515.1 million, or $0.85 and $2.38 per share, respectively.
DVA: 74.49 (-3.54)
Centura Health and DaVita HealthCare Partners Form New Joint Venture in Colorado and Kansas
PR Newswire - Thu Nov 06, 5:03AM CST
Centura Health and DaVita HealthCare Partners Inc. (NYSE: DVA) today announced a new joint venture that will offer a differentiated health care delivery model to help optimize health care value and lower costs for consumers in Colorado and Kansas. The two partners will combine their expertise to provide enhanced resources that increase coordination of care, equip care providers with sophisticated analytical tools and focus on prevention.
DVA: 74.49 (-3.54)
Will DaVita Healthcare (DVA) Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:40PM CST
DaVita Healthcare Partners, Inc. (DVA) is set to report third-quarter 2014 earnings on Nov 6, 2014.
MDVN: 112.77 (+7.82), AMSG: 51.50 (+0.16), DVA: 74.49 (-3.54), ALNY: 95.84 (+2.93)
Uptrend Call Working As DaVita Stock Rises 25.3% (DVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:38AM CST
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 25.26% as of today's recent price of $77.86. DVA: 74.49 (-3.54)
DaVita Kidney Care Highlights National Diabetes Month
PR Newswire - Mon Nov 03, 5:23AM CST
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, joins the fight against diabetes during National Diabetes Month this November by sharing suggestions and resources to help individuals manage the disease.
DVA: 74.49 (-3.54)
DaVita Kidney Care Shares Festive Halloween Recipes
PR Newswire - Fri Oct 31, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, shares a collection of Halloween recipes that are tasty alternatives for individuals on a kidney-friendly diet.
DVA: 74.49 (-3.54)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 67.97 (-0.30), ESRX: 77.87 (-0.05), DVA: 74.49 (-3.54), DGX: 61.69 (-1.07), MD: 62.18 (-0.43)
Why DaVita Healthcare Partners Inc. is 1 of the Biggest Warren Buffett Stocks
Selena Maranjian, The Motley Fool - Motley Fool - Wed Oct 29, 7:31AM CDT
Dialysis patient. Source: DaVita Healthcare Partners If you're in the market for some great stock ideas for your portfolio, it makes sense to study what the smartest and most successful investors own. Few, if any, investors are smarter or more...
DVA: 74.49 (-3.54)
DaVita Rx Opens State-of-the-Art Orlando Pharmacy
PR Newswire - Wed Oct 29, 5:23AM CDT
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today the grand opening of its new Orlando, Florida, pharmacy.
DVA: 74.49 (-3.54)
23.3% Return Seen to Date on SmarTrend DaVita Call (DVA)
Comtex SmarTrend(R) - Mon Oct 27, 9:16AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 23.26% as of today's recent price of $76.62. DVA: 74.49 (-3.54)
DaVita Kidney Care Finalizes DOJ Settlement
PR Newswire - Wed Oct 22, 7:01PM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), today announced it has finalized its comprehensive settlement with the U.S. Department of Justice and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners.
DVA: 74.49 (-3.54)
DaVita HealthCare Partners to Acquire Colorado Springs Health Partners
PR Newswire - Wed Oct 22, 5:38AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider of population health and kidney care services, today announced that HealthCare Partners has entered into an agreement to acquire Colorado Springs Health Partners (CSHP), a multi-specialty medical group with more than 100 physicians at 11 locations throughout the Pikes Peak region.
DVA: 74.49 (-3.54)
Dr. John Wigneswaran Joins Team at DaVita Kidney Care
PR Newswire - Tue Oct 21, 5:42AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named John Wigneswaran, M.D., as its new vice president of clinical affairs for hospital services.
DVA: 74.49 (-3.54)
DaVita Has Returned 17.0% Since SmarTrend Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 17, 5:09PM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 17.04% as of today's recent price of $72.75. DVA: 74.49 (-3.54)
